ObsTIVA‐UK: a service evaluation of obstetric total intravenous anaesthesia in the United Kingdom

Metodiev, Y. ORCID: https://orcid.org/0000-0003-0347-4693, Iliff, H. A., Sharif, B., Bell, S. F., Oliver, C., de Lloyd, L. and ObsTIVA‐UK Collaborators Group 2024. ObsTIVA‐UK: a service evaluation of obstetric total intravenous anaesthesia in the United Kingdom. Anaesthesia Reports 12 (1) , e12293. 10.1002/anr3.12293

PDF Download (965kB)

Abstract

Summary: We conducted a prospective observational service evaluation across the United Kingdom on the use of total intravenous anaesthesia (TIVA) for obstetric surgery between November 2022 and June 2023. The primary aim was to describe the incidence of TIVA for obstetric surgery within participating units, with secondary aims to describe maternal and neonatal postoperative recovery indicators. Of 184 maternity units in the United Kingdom, 30 (16%) contributed data to the service evaluation. There were 104 patients who underwent caesarean delivery under TIVA and 19 patients had TIVA for other reasons. Infusions of propofol and remifentanil were used in 100% and 84% of cases, respectively. Fifty‐nine out of 103 live neonates (57%) required some form of respiratory support. Of the neonates with recorded data, 73% and 17% had Apgar scores < 7 at 1 and 5 min respectively. No neonates were recorded to have Apgar scores < 7 at 10 min. Further prospective research is required to investigate the impact of obstetric TIVA on maternal and neonatal outcomes and inform best practice recommendations.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by/4.0/
Publisher:	Wiley
ISSN:	2637-3726
Date of Acceptance:	14 April 2024
Last Modified:	09 May 2024 09:45
URI:	https://orca.cardiff.ac.uk/id/eprint/168804

Actions (repository staff only)

Edit Item